These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27451359)

  • 1. Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria.
    Boyle MJ; Reiling L; Osier FH; Fowkes FJ
    Int J Parasitol; 2017 Feb; 47(2-3):99-104. PubMed ID: 27451359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
    França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
    Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.
    Duffy PE
    Expert Rev Vaccines; 2021 Feb; 20(2):185-198. PubMed ID: 33478283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the naturally acquired immune response to Plasmodium vivax malaria.
    Longley RJ; Sattabongkot J; Mueller I
    Parasitology; 2016 Feb; 143(2):154-70. PubMed ID: 26864134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
    Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
    PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-derived antibody profiles of malaria patients in Southwest India.
    Venkatesh A; Jain A; Davies H; Periera L; Maki JN; Gomes E; Felgner PL; Srivastava S; Patankar S; Rathod PK
    Malar J; 2019 Apr; 18(1):138. PubMed ID: 30995911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.
    Cao Y; Bansal GP; Merino K; Kumar N
    PLoS One; 2016; 11(7):e0158212. PubMed ID: 27438603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women.
    Fowkes FJ; McGready R; Cross NJ; Hommel M; Simpson JA; Elliott SR; Richards JS; Lackovic K; Viladpai-Nguen J; Narum D; Tsuboi T; Anders RF; Nosten F; Beeson JG
    J Infect Dis; 2012 Nov; 206(10):1612-21. PubMed ID: 22966126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine.
    Mo AX; McGugan G
    Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
    Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview: immunology of malaria and progress in malaria vaccine development.
    Tharavanij S
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
    [No Abstract]   [Full Text] [Related]  

  • 13. Live attenuated pre-erythrocytic malaria vaccines.
    Keitany GJ; Vignali M; Wang R
    Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
    Salwati E; Minigo G; Woodberry T; Piera KA; de Silva HD; Kenangalem E; Tjitra E; Coppel RL; Price RN; Anstey NM; Plebanski M
    J Infect Dis; 2011 Apr; 203(8):1192-1199. PubMed ID: 21451007
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ayadi I; Balam S; Audran R; Bikorimana JP; Nebie I; Diakité M; Felger I; Tanner M; Spertini F; Corradin G; Arevalo M; Herrera S; Agnolon V
    Front Immunol; 2020; 11():574330. PubMed ID: 33193361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
    Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants.
    Khaireh BA; Briolant S; Pascual A; Mokrane M; Machault V; Travaillé C; Khaireh MA; Farah IH; Ali HM; Abdi AI; Ayeh SN; Darar HY; Ollivier L; Waiss MK; Bogreau H; Rogier C; Pradines B
    Malar J; 2012 Nov; 11():395. PubMed ID: 23190709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
    Bennett JW; Yadava A; Tosh D; Sattabongkot J; Komisar J; Ware LA; McCarthy WF; Cowden JJ; Regules J; Spring MD; Paolino K; Hartzell JD; Cummings JF; Richie TL; Lumsden J; Kamau E; Murphy J; Lee C; Parekh F; Birkett A; Cohen J; Ballou WR; Polhemus ME; Vanloubbeeck YF; Vekemans J; Ockenhouse CF
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004423. PubMed ID: 26919472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
    George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
    mSphere; 2019 May; 4(3):. PubMed ID: 31092602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccine clinical trials: what's on the horizon.
    Moreno A; Joyner C
    Curr Opin Immunol; 2015 Aug; 35():98-106. PubMed ID: 26172291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.